Cover Image

Incidence and Predictors of Adverse Drug Events Among People Receiving Drug Resistant Tuberculosis Treatment in Uganda: 8-Year Retrospective Cohort Study

Marble Nasasira,1 Joan N Kalyango,1,2 Ezekiel Mupere,3 Joseph Baruch Baluku4,5 1Clinical Epidemiology Unit, Makerere University College of Health Sciences, Kampala, Uganda; 2Department of Pharmacy, Makerere University College of Health Sciences, Kampala, Uganda; 3Department of Paediatrics and Child...

Full description

Saved in:

Bibliographic Details
Main Authors:	Nasasira M (Author), Kalyango JN (Author), Mupere E (Author), Baluku JB (Author)
Format:	Book
Published:	Dove Medical Press, 2022-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Hospital admissions attributed to adverse drug reactions in tertiary care in Uganda: burden and contributing factors
by: Lillian Asio, et al.
Published: (2023)

Human Papillomavirus Vaccination Uptake and Its Predictors Among Female Adolescents in Gulu Municipality, Northern Uganda
by: Aruho C, et al.
Published: (2022)

Using INTERCheck® to Evaluate the Incidence of Adverse Events and Drug-Drug Interactions in Out- and Inpatients Exposed to Polypharmacy
by: Antonio Martocchia, et al.
Published: (2020)

High incidence of pulmonary tuberculosis in children admitted with severe pneumonia in Uganda
by: Nantongo Josephine M, et al.
Published: (2013)

Mortality rate and associated factors among patients co-infected with drug resistant tuberculosis/HIV at Mulago National Referral Hospital, Uganda, a retrospective cohort study.
by: Joan Rokani Bayowa, et al.
Published: (2023)

Incidence and Predictors of Adverse Drug Reactions Caused by Drug-Drug Interactions in Elderly Outpatients: A Prospective Cohort Study
by: Paulo Roque Obreli-Neto, et al.
Published: (2012)

When and how do individuals transition from regular drug use to injection drug use in Uganda? Findings from a rapid assessment
by: Matayo Baluku, et al.
Published: (2019)

Incidence and management of adverse events in patients with relapsed and/or refractory multiple myeloma receiving single-agent carfilzomib
by: Harvey RD
Published: (2014)

Incidence of drug-related adverse events related to the use of high-alert drugs: A systematic review of randomized controlled trials
by: Michelle Santos Menezes, et al.
Published: (2024)

Evaluation of the Direct Costs of Managing Adverse Drug Events in all Ages and of Avoidable Adverse Drug Events in Older Adults in Japan
by: Hayato Katsuno, et al.
Published: (2021)

Characteristics of pediatric adverse drug reaction reports in the Japanese Adverse Drug Event Report Database
by: Aoi Noda, et al.
Published: (2020)

Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
by: Han N, et al.
Published: (2021)

Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment
by: Lina Keutzer, et al.
Published: (2023)

Clinical drug interactions between voriconazole and 38 other drugs: a retrospective analysis of adverse events
by: Ben-Nian Huo, et al.
Published: (2024)

Prevalence of potential drug interactions in Thai patients receiving simvastatin: The causality assessment of musculoskeletal adverse events induced by statin interaction
by: Methira Siriangkhawut, et al.
Published: (2017)

HOSPITALIZATIONS DUE TO ADVERSE DRUG EVENTS IN THE ELDERLY - A RETROSPECTIVE REGISTER STUDY
by: Outi Laatikainen, et al.
Published: (2016)

A systematic review of flurbiprofen 8.75 mg dose and risk of adverse events (excluding haemorrhagic) resulting from drug-drug interactions
by: Alison Evans, et al.
Published: (2024)

Variation in adverse drug events of opioids in the United States
by: Edward Y. Liu, et al.
Published: (2023)

Predictors for Pulmonary Tuberculosis Outcome and Adverse Events in an Italian Referral Hospital: A Nine-Year Retrospective Study (2013-2021)
by: Francesco Di Gennaro, et al.
Published: (2022)

Improving drug safety in hospitals: a retrospective study on the potential of adverse drug events coded in routine data
by: Nils Kuklik, et al.
Published: (2019)

HIV- and hepatitis C-related risk behaviors among people who inject drugs in Uganda: implications for policy and programming
by: Matayo Baluku, et al.
Published: (2019)

Incidents and adverse events notified at hospital level
by: Andreia Mascarello, et al.
Published: (2021)

Vonoprazan-associated infection: an analysis of the Japanese Adverse Drug Event Report and the FDA Adverse Event Reporting System
by: Mengling Ouyang, et al.
Published: (2024)

Pattern of Adverse Drug Reactions and Performed Monitoring Laboratory-Tests in Patients Receiving Anti Tuberculosis Treatment in an Endemic Region, Zabol
by: Mandana Moradi, et al.
Published: (2024)

Clinical drug interactions between linezolid and other antibiotics: For adverse drug event monitoring
by: Ling Shu, et al.
Published: (2024)

Assessment and monitoring of biologic drug adverse events in patients with psoriasis
by: Hanley T, et al.
Published: (2016)

Role of the Clinical Pharmacist in Reducing Preventable Adverse Drug Events
by: Bahir A.Mshiemish
Published: (2017)

Drug interactions and adverse events in elderly heart disease patients
by: Fernanda Carolina Cruz Evangelista, et al.
Published: (2021)

Role of the Clinical Pharmacist in Reducing Preventable Adverse Drug Events
by: Bahir A.Mshiemish
Published: (2017)

HE USE OF TRIGGER TOOLSIN THE IDENTIFICATION OF ADVERSE DRUG EVENTS
by: Cleni Veroneze, et al.
Published: (2017)

Magnitude and Impacts of Adverse Events of Injectable Containing Shorter Regimen in Programmatic Management of Multi-Drug Resistant Tuberculosis in Ethiopia: A Retrospective Cohort Study
by: Achalu DL, et al.
Published: (2023)

Retrospective analysis of adverse events with spironolactone in females reported to the United States Food and Drug Administration
by: Yu Wang, BA, et al.
Published: (2020)

Hearing loss among patients on treatment for drug-resistant tuberculosis in Uganda
by: Lodiong Jackson Dumo Lodiong, et al.
Published: (2021)

Analysis of Adverse Events of Cholinesterase Inhibitors and NMDA Receptor Antagonists on Arrhythmias Using the Japanese Adverse Drug Event Report Database
by: Shotaro Kobayashi, et al.
Published: (2023)

Adverse drug events in the prevention and treatment of COVID-19: A data mining study on the FDA adverse event reporting system
by: Qiang Guo, et al.
Published: (2022)

Adverse events associated with molnupiravir: a real-world disproportionality analysis in food and drug administration adverse event reporting system
by: Yankun Liang, et al.
Published: (2023)

Analysis of fall-related adverse events among older adults using the Japanese Adverse Drug Event Report (JADER) database
by: Haruna Hatahira, et al.
Published: (2018)

Analyses of non-benzodiazepine-induced adverse events and prognosis in elderly patients based on the Japanese adverse drug event report database
by: Yoshihiro Noguchi, et al.
Published: (2018)

Adverse drug reactions in neonates: a brief analysis of the FDA adverse event reporting system
by: Pernille Kähler Byskov, et al.
Published: (2024)

A real-world study of antifibrotic drugs-related adverse events based on the United States food and drug administration adverse event reporting system and VigiAccess databases
by: Menglin He, et al.
Published: (2024)